Literature DB >> 1424624

Carbohydrate metabolism before and after Norplant removal.

J C Konje1, O A Odukoya, E O Otolorin, P D Ewings, O A Ladipo.   

Abstract

Changes in carbohydrate metabolism, measured by oral glucose tolerance test, were studied in Norplant users before and after removal. The mean area under the glucose curve rose from 24.7 min mmol/L before Norplant insertion to 35.1 min mmol/L before removal and decreased to 26.1 min mmol/L four weeks after Norplant removal. The areas before insertion and after removal were not statistically different (95% confidence interval -3.3 to 0.56, P = 0.16). The mean areas under the insulin curves before insertion (53.14 min uU/L) and after removal (59.46 min uU/L), however, were significantly different (95% confidence interval -7.64 to -5.0, P less than 0.0001). We conclude that changes in carbohydrate metabolism induced by Norplant are reversible once the implants are removed. While the changes in glucose induced by Norplant returned to pre-insertion levels within 4 weeks after removal, insulin changes were slower to return to pre-insertion values.

Entities:  

Keywords:  Africa; Africa South Of The Sahara; Biology; Carbohydrate Metabolic Effects; Clinical Research; Comparative Studies; Contraception; Contraceptive Implants--side effects; Contraceptive Methods--side effects; Developing Countries; Diabetes Mellitus; Diseases; English Speaking Africa; Examinations And Diagnoses; Family Planning; Glucose Metabolism Effects; Glucose Tolerance Test; Laboratory Examinations And Diagnoses; Laboratory Procedures; Metabolic Effects; Methodological Studies; Nigeria; Physiology; Research Methodology; Studies; Western Africa

Mesh:

Substances:

Year:  1992        PMID: 1424624     DOI: 10.1016/0010-7824(92)90132-d

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  3 in total

1.  Hormonal contraception and metabolic outcomes in women with or at risk for HIV infection.

Authors:  Julie A Womack; Rebecca Scherzer; Stephen R Cole; Kristopher Fennie; Ann B Williams; Margaret Grey; Howard Minkoff; Kathryn Anastos; Mardge H Cohen; Phyllis C Tien
Journal:  J Acquir Immune Defic Syndr       Date:  2009-12       Impact factor: 3.731

Review 2.  Levonorgestrel subdermal implants. A review of contraceptive efficacy and acceptability.

Authors:  A J Coukell; J A Balfour
Journal:  Drugs       Date:  1998-06       Impact factor: 9.546

Review 3.  Risks and benefits, advantages and disadvantages of levonorgestrel-releasing contraceptive implants.

Authors:  Irving Sivin
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.